Skip to content
Open access

Design, Synthesis, Structural Characterization, Analytical Method Development, and Comprehensive Pharmacological Evaluation of Novel Heterocyclic Benzothiazole-Based Hybrid Derivatives as Multi-Target Therapeutic Candidates for Inflammation and Oxidative Stress-Associated Disorders

Oct 2026 · International Journal of Drug Delivery Technology · 0 citations

Abstract

Inflammation and oxidative stress are closely interconnected pathological processes implicated in the onset and progression of numerous chronic disorders, including rheumatoid arthritis, cardiovascular diseases, neurodegenerative disorders, diabetes mellitus, and cancer. The development of multi-target therapeutic agents capable of simultaneously modulating inflammatory mediators and oxidative stress pathways has emerged as a promising strategy for improving treatment efficacy while minimizing adverse effects. In the present study, a series of twenty novel benzothiazole-based heterocyclic hybrid derivatives (BT-1 to BT-20) were rationally designed using a molecular hybridization approach and synthesized through optimized multistep synthetic protocols. The synthesized compounds were structurally characterized by Fourier-transform infrared (FT-IR) spectroscopy, ultraviolet-visible (UV–Vis) spectroscopy, proton nuclear magnetic resonance (¹H NMR), carbon-13 nuclear magnetic resonance (¹³C NMR), mass spectrometry, and elemental analysis. A reverse-phase high-performance liquid chromatography (RP-HPLC) method was successfully developed and validated according to International Council for Harmonisation (ICH Q2(R2)) guidelines for quantitative estimation of the synthesized derivatives. The pharmacological potential of the compounds was comprehensively evaluated through in vitro antioxidant assays, including DPPH, ABTS, ferric reducing antioxidant power (FRAP), and nitric oxide scavenging assays, together with anti-inflammatory investigations involving protein denaturation, membrane stabilization, cyclooxygenase (COX-1/COX-2) inhibition, lipoxygenase (LOX) inhibition, and cytotoxicity assessment using the MTT assay. In vivo pharmacological efficacy was further investigated using carrageenan-induced paw edema and formalin-induced inflammation models, followed by biochemical estimation of oxidative stress biomarkers and histopathological examination.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.